GFAP and neoplasm: Even at early time points, AAV6 predominantly transduces astrocytes identified as GFAP + RFP- (70–80% EGFP+ cells), with limited EGFP expression observed in RFP+ tumor cells (<15%) (Fig. 1g, Supplementary Fig. S4a).